DataLend presents its top 10 earnings equities for March 16, 2015. This list is built on DataLend¹s universe of more than 42,000 securities on loan.
Methodology: We scan our universe of more than 42,000 securities on loan to find those securities with the most expensive financing positions in the U.S., U.K., Europe and Asia. Financing costs are determined by taking the total on-loan value of a security and multiplying it by the volume-weighted average fees to borrow that security, then converting the product of those numbers to a dollar value. We then sort the most expensive securities to finance in the securities lending market in descending order.
US |
Utilization |
| 1 GAMESTOP CL A | 87.72% |
| 2 TRANSOCEAN | 87.38% |
| 3 NOW | 97.39% |
| 4 MANNKIND | 95.58% |
| 5 ULTRA PETROLEUM | 84.22% |
| 6 AMBARELLA | 90.48% |
| 7 3D SYSTEMS | 97.69% |
| 8 MYRIAD GENETICS | 91.45% |
| 9 INVENSENSE | 79.18% |
| 10 GREENBRIER | 97.90% |
UK |
Utilization |
| 1 TALKTALK TELECOM GROUP | 89.37% |
| 2 BP | 3.97% |
| 3 ASOS | 75.79% |
| 4 QUINDELL | 94.95% |
| 5 ASHMORE GROUP | 88.56% |
| 6 LONMIN | 93.12% |
| 7 JSC VTB BANK GDR | 25.62% |
| 8 SAINSBURYJ | 67.67% |
| 9 MONITISE | 53.65% |
| 10 APR ENERGY | 81.39% |
Europe |
Utilization |
| 1 TRANSOCEAN (CH) | 97.14% |
| 2 GEMALTO (NL) | 91.54% |
| 3 TOTAL (FR) | 30.09% |
| 4 GTECH (IT) | 90.78% |
| 5 TALKTALK TELECOM GROUP | 89.37% |
| 6 AIR FRANCE-KLM (FR) | 96.36% |
| 7 GEMALTO (FR) | 89.10% |
| 8 UNIBAIL RODAMCO REIT (NL) | 22.42% |
| 9 SUEDZUCKER MANNHEIM OCHSENFURT (DE) | 85.60% |
| 10 TGS NOPEC GEOPHYSICAL (NO) | 73.32% |
Far East/Australia Pacific |
Utilization |
| 1 HANERGY TFP (HK) | 94.94% |
| 2 CELLTRION (KR) | 79.63% |
| 3 EVERGRANDE (HK) | 87.87% |
| 4 DAUM KAKAO (KR) | 83.79% |
| 5 PRADA (HK) | 89.94% |
| 6 SANRIO (JP) | 83.16% |
| 7 MIXI (JP) | 82.51% |
| 8 CSR H (HK) | 69.81% |
| 9 GUNGHO ONLINE (JP) | 75.99% |
| 10 SHARP (JP) | 94.45% |
This is just a snapshot of the rich data and functionalities provided by DataLend. Click here for more information about DataLend’s key features.
THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.